Hailing from San Diego, insulin pump maker, Tandem Diabetes Care®, Inc. has gained U.S. FDA clearance to market the t:flex™ Insulin Pump, with its claim to have the largest capacity device of its kind currently available in the United States.
Background
Tandem Diabetes Care, Inc. says it adopts a user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company already manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market. Now its t:flex™ Insulin Pump, with its 480 unit reservoir, becomes the first pump designed for people with greater insulin requirements.
The t:flex Pump is expected to launch in the United States in the second quarter of 2015.
Company comments
“In recognizing that one size does not fit all, the t:flex Pump was developed using Tandem’s proprietary technology platform to bring t:slim’s benefits to people with greater insulin needs,” said Kim Blickenstaff, President and Chief Executive Officer of Tandem Diabetes Care. “This first expansion of our product portfolio reflects our ongoing commitment to deliver user-friendly products that address unmet needs in the diabetes community.”
Source: PR Newswire
published: January 13, 2015 in: Approval/Clearance, Healthcare